News

XORTX Therapeutics: Meeting Documents Now Available

XORTX Therapeutics: Meeting Documents Now Available

XORTX Announces Filing and Mailing of Meeting Documents

XORTX Therapeutics Inc. (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company dedicated to creating innovative therapies for progressive kidney disease, has made important announcements regarding its upcoming annual and special meeting of shareholders. The management information circular for this meeting is now available on the Company’s corporate website, reflecting their commitment to transparency and engagement with shareholders.

Availability of Meeting Documents

The management information circular includes essential information about the upcoming meeting, and shareholders are encouraged to review these materials carefully. This circular can be accessed not only on XORTX's official site but also on SEDAR+ and the SEC’s websites. By providing these documents, XORTX ensures that all shareholders have the necessary information to make informed voting decisions.

Important Meeting Details

XORTX has set the date for the annual and special meeting on September 12 at 10:00 AM (Calgary Time). The meeting will be held at the Company’s offices located at 3710 – 33rd Street NW. It is crucial for shareholders to participate and cast their votes, emphasizing that every vote counts, regardless of the number of shares owned.

Voting Process and Guidelines

Shareholders are urged to act promptly, as the voting deadline is 10:00 AM on September 10. For assistance, XORTX’s strategic advisor and proxy solicitation agent, Laurel Hill Advisory Group, is available to help with any voting inquiries. Shareholders can contact them by calling 1-877-452-7184 or emailing assistance@laurelhill.com.

Clarification of Important Information

The circular also includes a clarification regarding the participation of directors in previous board meetings. It specifically addresses the misreported attendance record of Patrick Treanor, who was not a board member during those meetings in 2023. This correction aims to provide shareholders with an accurate account of board activities.

Overview of XORTX Therapeutics Inc.

XORTX is leading the way in developing pharmaceutical solutions, with two significant products currently in late-stage clinical development. The primary program, XRx-008, targets Autosomal Dominant Polycystic Kidney Disease (ADPKD), while the secondary program, XRx-101, focuses on acute kidney and organ injuries associated with infections, including COVID-19. Additionally, XORTX is advancing XRx-225, which is in the pre-clinical stage and aims to address Type 2 Diabetic Nephropathy.

Clinical Development Focus

The Company’s dedication to innovative therapies is rooted in its understanding of aberrant purine metabolism and the role of xanthine oxidase inhibition in treating various kidney diseases. With a commitment to enhancing patient quality of life, XORTX continues to diligently progress through its clinical development stages.

Contact Information for Shareholders

For any questions, shareholders can reach out to Allen Davidoff, CEO, at adavidoff@xortx.com or +1 403 455 7727. Nick Rigopulos, Director of Communications, is also available for inquiries at nick@alpineequityadv.com or +1 617 901 0785. Additionally, Kim Golodetz from LHA Investor Relations can assist at kgolodetz@lhai.com or +1 212 838 3777.

Frequently Asked Questions

What is the purpose of the XORTX annual meeting?

The annual meeting allows shareholders to receive updates from the company, discuss financial performance, and vote on important business matters.

When is the deadline for shareholders to vote?

Shareholders must vote by 10:00 AM (Calgary Time) on September 10.

How can shareholders access the management circular?

Shareholders can find the management circular on XORTX's website, as well as through SEDAR+ and SEC websites.

Who should shareholders contact for voting assistance?

For help with voting, shareholders should contact Laurel Hill Advisory Group.

What are the main products in development by XORTX?

XORTX is working on XRx-008 and XRx-101, which target kidney diseases and related conditions, along with another program in the pre-clinical stage focusing on diabetic nephropathy.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

Updated Category News Views 2

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Continue Reading
CUBEX Lights Up Veterinary Care with Mini Essential

Updated Category News Views 5

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Continue Reading
Law Firm Gains Strength with Strategic New Hires

Updated Category News Views 1

Catching the latest twist in the legal scene, veteran criminal defense attorney John T. Floyd is stiffening the backbone of his Houston-based firm. Snagging both Christopher Choate and Mia Floyd, he's set to fortify his team representing folks caught in the snarl of Texas and federal criminal courts. New Faces, Massive Expertise Let's dig into Choate's credentials first....

Continue Reading
Are FULC, WEAV, TECH Shareholders Getting a Raw Deal?

Updated Category News Views 3

Pocketing Insider Gains Amidst Shareholder Concerns Let me tell you, it smells like another day in the financial jungle where insiders might be feasting while the regular Joe shareholders are left nibbling on crumbs. Fulcrum Therapeutics, Weave Communications, and Bio-Techne are in the crosshairs for deals that may favor those on the inside track over you and me, the...

Continue Reading
Sacrifice Unending: 9/11's Lingering Health Toll

Updated Category News Views 1

The Unseen Toll of 9/11 on the Firefighter Community Two and a half decades since that fateful morning of September 11, 2001, we're staring at a grim reality. The heroic souls of the New York City Fire Department (FDNY)—those who ran toward peril when others ran away—are still paying the price. Incredibly, more than 400 FDNY members have succumbed to World Trade...

Continue Reading
Job Market Shifts: Adaptation vs. Fairness Dilemma

Updated Category News Views 3

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

Continue Reading
Health Net's $2M Boost for Stanislaus Affordable Housing

Updated Category News Views 1

Joining the Fight Against California’s Housing Crisis Well, I'll be the first to say it's a breath of fresh air when a healthcare beast like Health Net starts investing in something as critical as affordable housing. This is no drop in the bucket—two million dollars is quite the commitment to fix some of the mess that’s been brewing in Stanislaus County, California....

Continue Reading
Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Updated Category News Views 1

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

Continue Reading
Facility Solutions Group Climbs to Top 18 Electrical Spot

Updated Category News Views 2

FSG Shines Brightly in Electrical Contractor Rankings Climbing the ladder is no easy feat, but Facility Solutions Group (FSG) has managed to climb, all the way to the #18 spot on Electrical Construction & Maintenance (EC&M) magazine's revered list of the Top Electrical Contractors in the U.S. It’s up from their previous rank of 22. When you think about the competitive...

Continue Reading
Woodpack Global Unveils Crate Design System: A New Era Begins

Updated Category News Views 2

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Continue Reading

Top 5 Most Recently Viewed Articles

Freddie Mac's Strategic Sale of $438 Million NPLs

Updated Category News Views 107

Freddie Mac Moves Forward with Significant NPL Sale Freddie Mac is taking bold steps to reshape its mortgage investments strategy by selling a substantial portfolio of non-performing loans (NPLs). With a total balance of around $438 million, this sale, which involves 2,201 deeply delinquent residential first lien loans, emphasizes Freddie Mac's continued commitment to...

Continue Reading
Replenish Nutrients Unveils Beiseker Facility Progress and Vision

Updated Category News Views 257

Replenish Nutrients Unveils Beiseker Facility Progress Replenish Nutrients Holding Corp. (CSE: ERTH, OTC: VVIVF) has exciting news regarding significant advancements at its Beiseker manufacturing facility. The company is nearing completion of substantial upgrades to the facility, achieving approximately 90% of its renovation goals. The finishing touches include...

Continue Reading
Smartphones Market Growth: $520 Billion Potential by 2030

Updated Category News Views 611

Transformation in the Global Smartphones Market The global smartphones market is on a remarkable growth trajectory, set to expand its valuation significantly in the coming years. Current projections indicate that the market could grow from approximately US$ 273.9 billion to a staggering US$ 520.7 billion by the year 2030, driven by a compound annual growth rate (CAGR) of...

Continue Reading
Growth Trends in the Philippines Generator Market Beyond 2025

Updated Category News Views 222

The Expanding Philippines Generator Market: An Overview The generator market in the Philippines is experiencing a significant transformation as it is projected to expand from a valuation of US$151.16 million in 2024 to an impressive US$360.82 million by 2035. This growth, characterized by a compound annual growth rate (CAGR) of 8.29% during the 2025–2035 period, is...

Continue Reading
MoonLake Immunotherapeutics Faces Securities Class Action Lawsuit

Updated Category News Views 194

MoonLake Immunotherapeutics Faces Class Action Lawsuit MoonLake Immunotherapeutics, a dynamic player in the biopharmaceutical sector, is drawing attention due to a recent class action lawsuit associated with securities fraud. This lawsuit has been initiated in light of serious allegations against the company regarding misleading information about its leading drug...

Continue Reading